IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Incannex to Acquire APIRx Pharmaceuticals, page-16

  1. 9 Posts.
    Under the strategic rationale:

    'Expand Incannex’s addressable markets globally and addressable market sizes by over US$400bn per annum'

    A solid bit of potential there by the sounds of it alongside all those patents!
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.